Literature DB >> 1437514

Drug transport across the blood--brain barrier. I. Anatomical and physiological aspects.

J B Van Bree1, A G De Boer, M Danhof, D D Breimer.   

Abstract

This review describes various aspects of the transport of drugs across the blood-brain barrier and comprises three parts. In this first part, the anatomical and physiological aspects of blood-brain transport are discussed. It appears that the blood-brain barrier has an anatomical basis at the endothelium of the capillary wall. This endothelium is characterized by the presence of very tight junctions. As a result, the transport by passive diffusion of drugs with a low lipophilicity, is restricted. For certain classes of closely related relatively hydrophilic compounds, however, the presence of specialized carrier systems has been demonstrated which may facilitate transport. Also evidence is presently available, that the permeability of the blood-brain barrier may be under active regulatory control. It is expected that improved knowledge of the anatomical and physiological aspects of the blood-brain barrier and its regulation will provide a scientific basis for the development of strategies to improve the transport of drugs into the central nervous system.

Mesh:

Substances:

Year:  1992        PMID: 1437514     DOI: 10.1007/bf01977618

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  40 in total

1.  The active and passive exchanges of inorganic ions through the surfaces of living cells and through living membranes generally.

Authors:  A KROGH
Journal:  Proc R Soc Med       Date:  1946-02-12

2.  Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability.

Authors:  J R PAPPENHEIMER; E M RENKIN; L M BORRERO
Journal:  Am J Physiol       Date:  1951-10

Review 3.  Blood-brain transport of nutrients. Introduction.

Authors:  W M Pardridge
Journal:  Fed Proc       Date:  1986-06

Review 4.  The development of the human blood-brain and blood-CSF barriers.

Authors:  K Møllgård; N R Saunders
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Jul-Aug       Impact factor: 8.090

5.  Astrocytes induce blood-brain barrier properties in endothelial cells.

Authors:  R C Janzer; M C Raff
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

6.  A study of intrathecal, cerebrospinal fluid-to-brain exchange.

Authors:  R B Aird
Journal:  Exp Neurol       Date:  1984-11       Impact factor: 5.330

7.  Facilitated transfer of glucose from blood into brain tissue.

Authors:  C Crone
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

8.  Characterization of endothelial cell transport in the developing mouse blood-brain barrier.

Authors:  A S Lossinsky; A W Vorbrodt; H M Wisniewski
Journal:  Dev Neurosci       Date:  1986       Impact factor: 2.984

9.  Fracture faces of zonulae occludentes from "tight" and "leaky" epithelia.

Authors:  P Claude; D A Goodenough
Journal:  J Cell Biol       Date:  1973-08       Impact factor: 10.539

10.  Junctions between intimately apposed cell membranes in the vertebrate brain.

Authors:  M W Brightman; T S Reese
Journal:  J Cell Biol       Date:  1969-03       Impact factor: 10.539

View more
  4 in total

Review 1.  Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1992-12-11

Review 2.  Lipophilicity and its relationship with passive drug permeation.

Authors:  Xiangli Liu; Bernard Testa; Alfred Fahr
Journal:  Pharm Res       Date:  2010-10-30       Impact factor: 4.200

Review 3.  Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm World Sci       Date:  1993-02-19

4.  Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor.

Authors:  D M Lambert; F Mergen; C F Berens; J H Poupaert; P Dumont
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.